Prener Anne 4
4 · Rubius Therapeutics, Inc. · Filed Jan 3, 2020
Insider Transaction Report
Form 4
Prener Anne
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-12-31+50,000→ 50,000 totalExercise: $9.50Exp: 2029-12-30→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option shall vest in equal quarterly installments over the twelve quarters following the grant date.